279 related articles for article (PubMed ID: 31118569)
1. Ocular surface squamous neoplasia: angiographic characteristics and response to subconjunctival/perilesional 5-fluorouracil injections.
Sun Y; Hua R
Drug Des Devel Ther; 2019; 13():1323-1334. PubMed ID: 31118569
[No Abstract] [Full Text] [Related]
2. Long-Term Efficacy and Safety of Subconjunctival/Perilesional 5-Fluorouracil Injections for Ocular Surface Squamous Neoplasia.
Sun Y; Hua R
Drug Des Devel Ther; 2020; 14():5659-5665. PubMed ID: 33376309
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Topical 5-Fluorouracil and Interferon Alfa-2b as Primary Treatment Modalities for Ocular Surface Squamous Neoplasia.
Venkateswaran N; Mercado C; Galor A; Karp CL
Am J Ophthalmol; 2019 Mar; 199():216-222. PubMed ID: 30471241
[TBL] [Abstract][Full Text] [Related]
4. Interferon Alfa 2b for Ocular Surface Squamous Neoplasia: Factors Influencing the Treatment Response.
Kaliki S; Bejjanki KM; Desai A; Mohamed A
Semin Ophthalmol; 2019; 34(7-8):465-472. PubMed ID: 31370766
[TBL] [Abstract][Full Text] [Related]
5. Corneal squamous neoplasia: masquerades and management outcomes at a rural eyecare centre.
Agarwal A; Kaliki S; Murthy SI
BMJ Case Rep; 2023 May; 16(5):. PubMed ID: 37130635
[TBL] [Abstract][Full Text] [Related]
6. Topical 5-fluorouracil 1% for moderate to extensive ocular surface squamous neoplasia in 73 consecutive patients: Primary versus secondary treatment.
Leventer I; Singh H; Pashaee B; Raimondo CD; Khakh CK; Martin JL; Acharya B; Zhang Q; Lally SE; Shields CL
Asia Pac J Ophthalmol (Phila); 2024; 13(2):100052. PubMed ID: 38521390
[TBL] [Abstract][Full Text] [Related]
7. Optical coherence tomography angiography in the evaluation of vascular patterns of ocular surface squamous neoplasia during topical medical treatment.
Theotoka D; Liu Z; Wall S; Galor A; Al Bayyat GJ; Feuer W; Jianhua W; Karp CL
Ocul Surf; 2022 Jul; 25():8-18. PubMed ID: 35358712
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of topical 5-Fluorouracil in the management of ocular surface squamous neoplasia: a study of 101 eyes.
Bakal K; Molugu S; Machakuri K; Bejjanki KM; Kapoor AG; Kaliki S
Int Ophthalmol; 2024 Jun; 44(1):251. PubMed ID: 38907750
[TBL] [Abstract][Full Text] [Related]
9. Subconjunctival/perilesional recombinant interferon α2b for ocular surface squamous neoplasia: a 10-year review.
Karp CL; Galor A; Chhabra S; Barnes SD; Alfonso EC
Ophthalmology; 2010 Dec; 117(12):2241-6. PubMed ID: 20619462
[TBL] [Abstract][Full Text] [Related]
10. Ultra-high resolution optical coherence tomography for differentiation of ocular surface squamous neoplasia and pterygia.
Kieval JZ; Karp CL; Abou Shousha M; Galor A; Hoffman RA; Dubovy SR; Wang J
Ophthalmology; 2012 Mar; 119(3):481-6. PubMed ID: 22154538
[TBL] [Abstract][Full Text] [Related]
11. Topical 1% 5-fluoruracil as a sole treatment of corneoconjunctival ocular surface squamous neoplasia: long-term study.
Parrozzani R; Frizziero L; Trainiti S; Testi I; Miglionico G; Pilotto E; Blandamura S; Fassina A; Midena E
Br J Ophthalmol; 2017 Aug; 101(8):1094-1099. PubMed ID: 27941046
[TBL] [Abstract][Full Text] [Related]
12. Immunosuppression as a Possible Risk Factor for Interferon Nonresponse in Ocular Surface Squamous Neoplasia.
Ashkenazy N; Karp CL; Wang G; Acosta CM; Galor A
Cornea; 2017 Apr; 36(4):506-510. PubMed ID: 28129301
[TBL] [Abstract][Full Text] [Related]
13. [Histopathology manifestation and imaging characteristics of
Liang QF; Huang JJ; Cao K; Su GY; Wang ZQ; Zhang Y; Li B
Zhonghua Yan Ke Za Zhi; 2018 Sep; 54(9):652-660. PubMed ID: 30220179
[No Abstract] [Full Text] [Related]
14. Role of high resolution optical coherence tomography in diagnosing ocular surface squamous neoplasia with coexisting ocular surface diseases.
Atallah M; Joag M; Galor A; Amescua G; Nanji A; Wang J; Perez VL; Dubovy S; Karp CL
Ocul Surf; 2017 Oct; 15(4):688-695. PubMed ID: 28347855
[TBL] [Abstract][Full Text] [Related]
15. Topical 5-Fluorouracil 1% as Primary Treatment for Ocular Surface Squamous Neoplasia.
Joag MG; Sise A; Murillo JC; Sayed-Ahmed IO; Wong JR; Mercado C; Galor A; Karp CL
Ophthalmology; 2016 Jul; 123(7):1442-8. PubMed ID: 27030104
[TBL] [Abstract][Full Text] [Related]
16. Topical chemotherapy for giant ocular surface squamous neoplasia of the conjunctiva and cornea: Is surgery necessary?
Chaugule SS; Park J; Finger PT
Indian J Ophthalmol; 2018 Jan; 66(1):55-60. PubMed ID: 29283124
[TBL] [Abstract][Full Text] [Related]
17. High-Resolution Anterior Segment Optical Coherence Tomography in Intraepithelial Versus Invasive Ocular Surface Squamous Neoplasia.
Singh S; Mittal R; Ghosh A; Tripathy D; Rath S
Cornea; 2018 Oct; 37(10):1292-1298. PubMed ID: 29985794
[TBL] [Abstract][Full Text] [Related]
18. Subconjunctival bevacizumab injection for ocular surface squamous neoplasia.
Faramarzi A; Feizi S
Cornea; 2013 Jul; 32(7):998-1001. PubMed ID: 23538634
[TBL] [Abstract][Full Text] [Related]
19. Topical 1% 5-fluorouracil eye drops as primary treatment for ocular surface squamous neoplasia: Long-term follow-up study.
Wylegala A; Sripawadkul W; Zein M; Alvarez OP; Al Bayyat G; Galor A; Karp CL
Ocul Surf; 2023 Jan; 27():67-74. PubMed ID: 36476665
[TBL] [Abstract][Full Text] [Related]
20. Anterior segment optical coherence tomography characteristics of conjunctival papilloma as compared to papilliform ocular surface squamous neoplasia.
Sripawadkul W; Khzam RA; Tang V; Zein M; Dubovy SR; Galor A; Karp CL
Eye (Lond); 2023 Apr; 37(5):995-1001. PubMed ID: 36402855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]